Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice

Sandra Novoa Jáuregui, Laura Palomo, Ana Pérez, Bárbara Tazón, Maria Julia Montoro, Adoracion Blanco, Silvia Saumell, Laura Gallur, Eugenia Rivero, Sara Garrido, Marc Bosch Schips, Sofia Laura Muzio, Margarita Ortega, Antonieta Molero Yordi, Francesc Bosch, David Valcárcel

Blood (2022) 140 (Supplement 1): 6966–6967.

https://doi.org/10.1182/blood-2022-168705

Published: 2022

Journal Articles

TP53 Allelic State in Myelodysplastic Syndromes with 5q Deletion

Maria Julia Montoro Gómez, Laura Palomo, Pablo Vidal, Francisco Fuster-Tormo, Esperanza Such, Margarita Ortega, Teresa González, Felix Lopez-Cadenas, Sara Garcia-Avila, Nieves Garcia-Gisbert, Elvira Mora Casterá, Eugenia Rivero, Francesc Bosch, Andrés Jerez, Maria Diez-Campelo, Francesc Solé, David Valcárcel

Blood (2022) 140 (Supplement 1): 6949–6951.

https://doi.org/10.1182/blood-2022-165257

Published: 2022

Journal Articles

Characterization of Terminal Erythroid Differentiation (TED) and Its Prognosis Impact Inpatients with Myelodysplastic Syndrome (MDS)

Marc Bosch Schips, Julia Montoro, Félix López Cadenas, Alba Mesa, Víctor Navarro Garcés, Ana Pérez, Laura Gallur, Silvia Saumell, Mayda Navarrete, Margarita Ortega, Bárbara Tazón, Antonieta Molero, Olga Salamero, Sandra Novoa Jáuregui, Sofia Laura Muzio, Francesc Bosch, David Valcárcel

Blood (2022) 140 (Supplement 1): 12308–12310.

https://doi.org/10.1182/blood-2022-157434

Published: 2022

Journal Articles

A Revised International Prognostic Scoring System of 3.5 Points Stratifies Patients with Myelodysplastic Syndromes into 2 Risk Categories

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-136197

Published: 2020

Journal Articles

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

Blood (2019) 134 (Supplement_1): 4287.

https://doi.org/10.1182/blood-2019-126557

Published: 2019

Journal Articles

Morphologic Assessment of Terminal Erythroid Differentiation Predicts Outcomes in Myelodysplastic Syndromes

Maria Julia Montoro, MD, Ana Perez, MD, Silvia Saumell, MD PhD, Maida Navarrete, MD, Gael Roue, PhD, Moraima Jimenez, MD, Margarita Ortega, PhD, Bárbara Tazón, PhD, Antonieta Molero, MD, Olga Salamero, MD, Francesc Bosch, MD PhD, David Valcarcel, MD

Blood (2019) 134 (Supplement_1): 3011.

https://doi.org/10.1182/blood-2019-123185

Published: 2019

Journal Articles

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Blood (2019) 134 (Supplement_1): 2612.

https://doi.org/10.1182/blood-2019-129153

Published: 2019

Journal Articles

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Blood (2016) 128 (22): 4331.

https://doi.org/10.1182/blood.V128.22.4331.4331

Published: 2016

Journal Articles

Cytogenetic Evolution in Patients with IPSS Low and Intermediate-1 Risk. Study from the Spanish Group of Myelodysplastic Syndrome

Brayan Marcel Merchán, MD, Margarita Ortega, María José Llamas-Poyato, Montserrat Cortés, Montserrat Arnan, MD, Carlos Cerveró, MD, Julia Montoro, MD, Teresa Gimenez, MD, María López, Leonor Arenillas, MD, David Valcárcel, MD PhD

Blood (2014) 124 (21): 4649.

https://doi.org/10.1182/blood.V124.21.4649.4649

Published: 2014

Journal Articles

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Blood (2014) 124 (21): 3240.

https://doi.org/10.1182/blood.V124.21.3240.3240

Published: 2014

Journal Articles

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Blood (2014) 124 (21): 5638.

https://doi.org/10.1182/blood.V124.21.5638.5638

Published: 2014

Journal Articles

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Blood (2012) 120 (21): 702.

https://doi.org/10.1182/blood.V120.21.702.702

Published: 2012

Journal Articles

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Julia Montoro, MD, Teresa Vallespi, MD, PhD, Esther Sancho, MD, Olga Salamero, MD, Laura Lopez-Andreoni, MD, Carmen sanchez-Morata, MD, Mayda Navarrete, MD, Margarita Ortega, PhD, Sabela Bobillo, MD, Noelia Valdez, MD, Francesc Bosch, MD, PhD, David Valcárcel, MD

Blood (2011) 118 (21): 5026.

https://doi.org/10.1182/blood.V118.21.5026.5026

Published: 2011

Journal Articles

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

David Valcárcel, MD, Vera Adema, Mar Mallo, Margarita Ortega, PhD, Benet Nomdedeu, MD, Guillermo Sanz, MD, Elisa Luño, MD, Del CaÃ‘izo Consuelo, MD, PhD, Javier De la Serna, MD, PhD, Maita Ardanaz, MD, Victor Marco, MD, Rosa Collado, Blanca Xicoy, MD, Francesc Sole, PhD, Teresa Vallespi, MD, PhD

Blood (2011) 118 (21): 1724.

https://doi.org/10.1182/blood.V118.21.1724.1724

Published: 2011

Journal Articles

T(8;22)(q24;q11) In a Context of Complex Karyotype In Two Patients with B-Cell Lymphoma with Features Intermediate Between Burkitt Lymphoma and Diffuse Large B Cell Lymphoma B (LB/LDCGB)

Teresa Vallespi, MD, PhD, Margarita Ortega, PhD, Anny Jaramillo, MD, Laura Lopez-Andreoni, MD, Noemi Martínez-Morgado, Carmen Sánchez, MD, Francesc Bosch, MD, PhD

Blood (2010) 116 (21): 5093.

https://doi.org/10.1182/blood.V116.21.5093.5093

Published: 2010

Journal Articles

Therapy-Related PML-RARα Leukemia: An Emerging Disease. Report of 10 Cases From One Department of Hematology.

Maida Navarrete, MD, Teresa Vallespi, MD, PhD, Anny Jaramillo, MD, Carmen Sánchez-Morata, MD, Carlos Palacio, MD, Noemí Martínez-Morgado, Ángel Guerra-Moreno, Margarita Ortega, PhD, Javier Bueno, MD

Blood (2009) 114 (22): 1016.

https://doi.org/10.1182/blood.V114.22.1016.1016

Published: 2009

Journal Articles

Global DNA Methylation Status of CD4+ T-Cell Population in Mielodysplastic Syndromes.

Angel Guerra-Moreno, Carlos Palacio, MD, Noemí Martínez-Morgado, Margarita Ortega, Maida Navarrete, M.D., Carmen Sánchez-Morata, M.D., Laura Gallur, MD, Javier Bueno, Teresa Vallespi, MD.PhD.

Blood (2009) 114 (22): 4424.

https://doi.org/10.1182/blood.V114.22.4424.4424

Published: 2009

NARROW

IPSS-M Applicability and Clinical Impact in Decision-Making Process in Real-Life Clinical Practice

TP53 Allelic State in Myelodysplastic Syndromes with 5q Deletion

Characterization of Terminal Erythroid Differentiation (TED) and Its Prognosis Impact Inpatients with Myelodysplastic Syndrome (MDS)

A Revised International Prognostic Scoring System of 3.5 Points Stratifies Patients with Myelodysplastic Syndromes into 2 Risk Categories

Chromosome Banding Analysis Versus Genomic Microarrays: A Comparison of Methods for Genomic Complexity Risk Stratification in Chronic Lymphocytic Leukemia Patients with Complex Karyotype

Morphologic Assessment of Terminal Erythroid Differentiation Predicts Outcomes in Myelodysplastic Syndromes

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Isolate Loss of Y Chromosome Decreases the Risk of Leukemic Transformation in the Myelodysplastic Syndromes. a Study By the Spanish Group of Myelodysplastic Syndromes

Cytogenetic Evolution in Patients with IPSS Low and Intermediate-1 Risk. Study from the Spanish Group of Myelodysplastic Syndrome

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome

Chromosome 8 Abnormalities (8p Losses and 8q Gains) in Patients with Chronic Lymphocytic Leukemia (CLL) and Del(17p)

Identification of Poor Risk Patients in Low and Intermediate-1 (Int-1) IPSS MDS with the New Ipssr Index and Comparison with Other Prognostic Indexes. A Study by the Spanish Group of MDS (GESMD)

Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience

Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

T(8;22)(q24;q11) In a Context of Complex Karyotype In Two Patients with B-Cell Lymphoma with Features Intermediate Between Burkitt Lymphoma and Diffuse Large B Cell Lymphoma B (LB/LDCGB)

Therapy-Related PML-RARα Leukemia: An Emerging Disease. Report of 10 Cases From One Department of Hematology.

Global DNA Methylation Status of CD4+ T-Cell Population in Mielodysplastic Syndromes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only